Oral Immunization Against Candidiasis Using Lactobacillus casei Displaying Enolase 1 from Candida albicans

Article, Other literature type English OPEN
SHIBASAKI, Seiji; KARASAKI, Miki; TAFUKU, Senji; AOKI, Wataru; SEWAKI, Tomomitsu; UEDA, Mitsuyoshi;
(2014)
  • Publisher: Austrian Pharmaceutical Society
  • Journal: Scientia Pharmaceutica,volume 82,issue 3,pages697-708 (issn: 2218-0532, eissn: 2218-0532)
  • Publisher copyright policies & self-archiving
  • Related identifiers: pmc: PMC4318230, doi: 10.3797/scipharm.1404-07
  • Subject: Research Article | Molecular display technology | </i>Molecular display technology | Eno1p | Lactococcus casei | Candida albicans | Candidiasis | <i>Candida albicans
    mesheuropmc: food and beverages

Abstract Candidiasis is a common fungal infection that is prevalent in immunocompromised individuals. In this study, an oral vaccine against Candida albicans was developed by using the molecular display approach. Enolase 1 protein (Eno1p) of C. albicans was expressed on... View more
  • References (35)
    35 references, page 1 of 4

    Clin Microbiol Rev. 2007; 20: 133-163.

    http://dx.doi.org/10.1128/CMR.00029-06

    Microbiol Mol Biol Rev. 2003; 67: 400-428.

    http://dx.doi.org/10.1128/MMBR.67.3.400-428.2003

    J Clin Microbiol. 1996; 34: 2497-2499.

    http://www.ncbi.nlm.nih.gov/pubmed/8880507

    J Infect Dis. 2001; 184: 1489-1493.

    http://dx.doi.org/10.1086/324532

    Annu Rev Genet. 2007; 41: 193-211.

    http://dx.doi.org/10.1146/annurev.genet.41.042007.170146

  • Metrics
Share - Bookmark